Clinical Trial Update: A Study to Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants of Moderate-to-severe Plaque Psoriasis [NA]

View source ↗

Summary

This clinical trial is evaluating high-dose and extended-interval guselkumab regimens compared with standard-dose in Chinese participants with moderate-to-sever…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• TREMFYA (guselkumab)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Psoriasis | NA | Status: RECRUITING